AAAAAA

   
Results: 1-7 |
Results: 7
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection
Authors: Ortiz, GM Hu, J Goldwitz, JA Chandwani, R Larsson, M Bhardwaj, N Bonhoeffer, S Ramratnam, B Zhang, LQ Markowitz, MM Nixon, DF
Citation: Gm. Ortiz et al., Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8(+) T-cell responses in subjects treated early after infection, J VIROLOGY, 76(1), 2002, pp. 411-415
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
Authors: Garcia, F Plana, M Ortiz, GM Bonhoeffer, S Soriano, A Vidal, C Cruceta, A Arnedo, M Gil, C Pantaleo, G Pumarola, T Gallart, T Nixon, DF Miro, JM Gatell, JM
Citation: F. Garcia et al., The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F29-F40
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
Authors: Ortiz, GM Wellons, M Brancato, J Vo, HTT Zinn, RL Clarkson, DE Van Loon, K Bonhoeffer, S Miralles, GD Montefiori, D Bartlett, JA Nixon, DF
Citation: Gm. Ortiz et al., Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects, P NAS US, 98(23), 2001, pp. 13288-13293
Risks and benefits of structured antiretroviral drug therapy interruptionsin HIV-1 infection
Authors: Bonhoeffer, S Rembiszewski, M Ortiz, GM Nixon, DF
Citation: S. Bonhoeffer et al., Risks and benefits of structured antiretroviral drug therapy interruptionsin HIV-1 infection, AIDS, 14(15), 2000, pp. 2313-2322
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption
Authors: Papasavvas, E Ortiz, GM Gross, R Sun, JW Moore, EC Heymann, JJ Moonis, M Sandberg, JK Drohan, LA Gallagher, B Shull, J Nixon, DF Kostman, JR Montaner, LJ
Citation: E. Papasavvas et al., Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption, J INFEC DIS, 182(3), 2000, pp. 766-775
The relationship between T cell proliferative responses and plasma viremiaduring treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy
Authors: Binley, JM Schiller, DS Ortiz, GM Hurley, A Nixon, DF Markowitz, MM Moore, JP
Citation: Jm. Binley et al., The relationship between T cell proliferative responses and plasma viremiaduring treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy, J INFEC DIS, 181(4), 2000, pp. 1249-1263
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
Authors: Ortiz, GM Nixon, DF Trkola, A Binley, J Jin, X Bonhoeffer, S Kuebler, PJ Donahoe, SM Demoitie, MA Kakimoto, WM Ketas, T Clas, B Heymann, JJ Zhang, LQ Cao, YZ Hurley, A Moore, JP Ho, DD Markowitz, M
Citation: Gm. Ortiz et al., HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy, J CLIN INV, 104(6), 1999, pp. R13-R18
Risultati: 1-7 |